CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Dapsone 7.5 % geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02944461
NCT02944461Phase 4Completed
CompareCT.gov

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Derm Research, PLLC·interventional·Posted Oct 25, 2016·Updated Apr 3, 2019

In Brief

A Phase 4 clinical trial evaluating Dapsone 7.5 % gel for Acne. Completed, enrolled 20 participants across 3 sites.

Detailed Summary

To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 25, 2016
Enrollment StartOct 1, 2016
Primary CompletionSep 1, 2017
Study CompletionSep 11, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.7 years ago

Interventions

Dapsone 7.5 % geldrug

Dapsone gel 7.5% applied once daily to truncal acne